| 名称 | AC-73 |
| 描述 | AC-73 is an orally available Cluster of Differentiation 147 (CD147) inhibitor with high bioavailability that selectively disrupts the dimerization of CD147 (the binding site is in the N-terminal IgC2 domain of CD147 including Glu64 and Glu73), resulting in inhibition of the CD147/ERK1/2/STAT3/MMP-2 pathway and inhibition of liver cancer cell motility and invasion. AC-73 has antiproliferative activity and induces autophagy in leukemia cells. |
| 体外活性 | AC-73 (5-10 μM; 24 hours; SMMC-7721 and Huh-7 cells) treatment results in a dose-dependent reduction in the migration and invasion of these HCC cell lines, with no significant effect on cell viability at 20 μM. AC-73 potentially binds to CD147 at Glu64 and Glu73 in the N-terminal IgC2 domain, which are located within the CD147 dimer interface. AC-73 (5-10 μM; 24 hours; SMMC-7721 cells), at 10 μM, significantly inhibits the mRNA expression of MMP-2 and MMP-9, especially MMP-2, without affecting MMP-1, MMP-3, MMP-7, MMP-11, or MMP-13, and reduces MMP-2 mRNA levels and protein secretion as confirmed by RT-qPCR and gelatin zymography. AC-73 (5-20 μM; 6 hours; SMMC-7721 cells) also dose-dependently attenuates ERK1/2 and STAT3 phosphorylation. |
| 体内活性 | AC-73 (25-50 mg/kg; Injected; daily; for 3 weeks; Male BALB/c nu/nu mice with SMMC-7721 cells) treatment significantly decreases the incidence of metastatic foci in nude mice, inhibits the phosphorylation of ERK1/2 and STAT3 in a dose-dependent manner, and reduces MMP-2, but does not inhibit tumor cell proliferation in vivo.[1] |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | DMSO : 100 mg/mL (313.09 mM)
|
| 关键字 | AC 73 | AC73 | AC-73 |
| 相关产品 | Stavudine | Xylitol | Myricetin | Sodium 4-phenylbutyrate | Hydroxychloroquine | Guanidine hydrochloride | Taurine | Curcumin | Oxyresveratrol | Paeonol | Naringin | Gefitinib |
| 相关库 | 经典已知活性库 | 自噬库 | 抑制剂库 | 已知活性化合物库 |
United States
